NAD+ SubQ vs NAD+ IV: How to Choose Between Them

Radiance NAD+ SubQ and the IV options — Radiance NAD+ 250 and 500 — are all part of Brillaré's NAD+ collection. They deliver the same molecule, NAD+, but through different routes: the subcutaneous option into tissue beneath the skin, and the IV options through a vein. That difference in route is the easiest thing to compare — and the easiest thing to overvalue. The routes describe how the NAD+ is delivered, not which option is more suitable or more effective for you.

That positioning is useful for orientation, but it is not a ranking. Nothing about the routes implies that SubQ is better or worse than IV, and nothing about a particular route confirms that it produces a stronger result. The menu is a map of what is offered; the question of what fits you is separate.

When you compare, start by noticing what each option is anchored to, rather than what it is named. All three are anchored to the same molecule; the differences are route, listed amount, and pricing structure. A provider can walk you through what those differences mean in context, which is far more informative than comparing routes in isolation.

The subcutaneous route can make the SubQ option feel like the simpler, quicker choice, and that clarity can feel reassuring. A route, however, is not the same as a result. The fact that an option uses a different route does not confirm that it will improve energy, support cellular wellness in a way you can feel, or produce a noticeable benefit for you. Reading the comparison honestly means treating the route as orientation, not as a substitute for clinical assessment.

This matters most when a route tempts you to skip questions. A quicker-feeling option can make it feel like the obvious choice around convenience, but there is no obvious choice in clinical suitability — only what fits your history and your reasons. Asking what each option is offered for, and whether it is relevant to you, turns a comfortable route into an honest decision.

A useful habit: whenever SubQ feels like the obvious choice because of its convenience, translate that route into a question. 'What would this route mean for someone like me, and would my reasons match it?' That translation is the difference between choosing by route and choosing by fit.

On Brillaré's menu, the IV options are listed at $699 and $899, while the subcutaneous option starts at $199 per week. The price differences generally reflect the route, the listed amount, and the pricing structure — not a measure of how suitable or effective an option is for you. A lower weekly starting price does not establish that SubQ is better, and it does not mean SubQ is more effective than the IV options.

This is a common point of confusion. People sometimes assume that the lower-priced SubQ must be a more accessible and therefore more appropriate option. Neither is supported by the menu alone. What you get with a different price is a different offering; whether that offering is appropriate and beneficial for you is a clinical question, not a price question.

If cost is part of your decision, say so. A provider can help you weigh whether SubQ is relevant to your situation or whether an IV option would be just as appropriate. Comparing value meaningfully requires that clinical input — it cannot be done from the price column alone.

The subcutaneous option's weekly pricing structure is distinct from the IV options' per-visit pricing. That structure describes how SubQ is offered and priced; it does not establish a specific frequency, a recommended schedule, or self-administration. Whether a weekly pattern fits your situation is a clinical question — not something a pricing structure can answer.

It can be tempting to assume that because SubQ is priced weekly, a weekly pattern is implied or recommended. That reasoning is not supported by the menu alone. A pricing structure tells you how the option is offered; it does not tell you how often it is appropriate for you. A provider can help you understand what the structure means in context and whether a regular pattern is suitable given your history.

Reading the pricing structure honestly means treating it as information about the offering, not as a recommendation about frequency. The same applies to the route: a subcutaneous delivery tells you what is offered, not what is right for you. Both are orientation, not assessment.

A comparison is only as good as the questions behind it. Ask: Is SubQ relevant to my situation, or would an IV option be a better fit — and why? Is there anything in my history that makes a particular route less suitable? What does the weekly pricing mean for me — is a weekly pattern appropriate, or not? What does suitability depend on, and how is it screened?

Also ask about alternatives and coverage. If an option is not appropriate, what happens next? And does mobile availability extend to your exact location? The service-area directory is a planning list, not a guaranteed radius, so an option that fits you clinically still has to fit you logistically.

Finally, ask how the comparison interacts with any regular use. If you are considering membership-style regular treatments, the comparison changes — an inclusion is not a recommendation that an option suits you clinically, and the same screening applies each time. Comparing well means thinking about both the single visit and the longer pattern.

The point of comparing options is not to arrive at the perfect choice by yourself — it is to arrive at a consultation ready to ask better questions. When you can say 'I noticed SubQ and IV differ mainly in route and pricing structure; what would that difference mean for me?' you turn a menu into a productive conversation. The provider's role is to interpret the comparison against your history and confirm what is appropriate.

Brillaré serves Kissimmee and surrounding Central Florida communities as a mobile service, so the consultation often happens around the appointment request. Share your general location and the options you are considering, ask about availability, and bring the questions above. The combination — a thoughtful comparison and an honest provider — is what turns the choice between routes into one good decision.

And remember: a responsible outcome may be SubQ, an IV option, or none at all. Each of those is legitimate. The goal is a fit that actually serves you, not a choice that simply felt like the right route.